Capra Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 15

Capra Biosciences General Information

Description

Operator of a bioreactor platform intended to make a way to produce bio-based chemicals. The company's platform can reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels, enabling clients to produce hydrophobic products like retinol and performance lubricants.

Contact Information

Website
www.caprabiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 International Drive
  • Suite 100
  • Sterling, VA 20166
  • United States
+1 (202)
Primary Industry
Specialty Chemicals
Other Industries
Other Commercial Products
Biotechnology
Vertical(s)
CleanTech, Life Sciences
Corporate Office
  • 101 International Drive
  • Suite 100
  • Sterling, VA 20166
  • United States
+1 (202)

Capra Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Capra Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 01-Oct-2024 $500K Completed Generating Revenue
3. Seed Round 06-Dec-2023 Completed Generating Revenue
2. Seed Round 25-Apr-2023 $2M $2.5M Completed Generating Revenue
1. Seed Round 03-Jun-2021 $500K $500K Completed Generating Revenue
To view Capra Biosciences’s complete valuation and funding history, request access »

Capra Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
Seed-1
Seed-2 2,083 $0.000100 6% $120 $120 1x $120 2.83%
To view Capra Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Capra Biosciences Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 13

    Pending

  • Expiring in next 12 mo

Capra Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026161686-A2 Bioprocess systems and/or methods and optogenetic latching switches Pending 27-Jan-2025
WO-2026161686-A3 Bioprocess systems and/or methods and optogenetic latching switches Pending 27-Jan-2025
AU-2023322004-A1 Circulating biofilm bioreactor Pending 10-Aug-2022
EP-4569075-A1 Circulating biofilm bioreactor Pending 10-Aug-2022
US-20260347739-A1 Circulating biofilm bioreactor Pending 10-Aug-2022 C12M23/58
To view Capra Biosciences’s complete patent history, request access »

Capra Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Capra Biosciences Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Drive Catalyst Corporate Venture Capital Minority
Groundswell Ventures Venture Capital Minority
Alumni Ventures Venture Capital Minority
Closed Loop Partners Other Private Equity Minority
First Bight Ventures Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Ready to get started?

Request a free trial

Capra Biosciences FAQs

  • When was Capra Biosciences founded?

    Capra Biosciences was founded in 2020.

  • Where is Capra Biosciences headquartered?

    Capra Biosciences is headquartered in Sterling, VA.

  • What is the size of Capra Biosciences?

    Capra Biosciences has 25 total employees.

  • What industry is Capra Biosciences in?

    Capra Biosciences’s primary industry is Specialty Chemicals.

  • Is Capra Biosciences a private or public company?

    Capra Biosciences is a Private company.

  • What is Capra Biosciences’s current revenue?

    The current revenue for Capra Biosciences is .

  • How much funding has Capra Biosciences raised over time?

    Capra Biosciences has raised $6.4M.

  • Who are Capra Biosciences’s investors?

    Drive Catalyst, Groundswell Ventures, Alumni Ventures, Closed Loop Partners, and First Bight Ventures are 5 of 15 investors who have invested in Capra Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process